The U.K. is the top pick for high school students, and the U.S. is most popular for undergrad and graduate studies
A presentation by Western States Petroleum Association, one of the most powerful oil and gas lobbies, details an elaborate plan to thwart California's move away from fossil fuels
Calorie counts may not persuade people to order healthy food, but they might prod restaurants into slimming down what's on the menu
Ricardo Reyes previously ran communications at Tesla until 2012
The Wall Street investment bank has a new measure of consumer spending power it says points to "ending the year on a strong note"
How to cope with a traveler's headache: a winter storm across the East Coast on a day when 46 million Americans hit the roads and airports
Graduate students get paid close to the minimum wage to do high-level coding work for tech companies
Few small businesses have a real, rational marketing budget. Here’s why that’s OK
Founders: Dr. Daniel J. Abrams; Tom Anchordoquy, PhD; and Karen Stevens, PhD
VC Investment over the last four quarters: $21.5 million
Founded in 2005, this seven-person biopharmaceutical company develops drugs for the treatment of severe central nervous system diseases. In addition to VC funding, Sierra received about $230,000 in grants from the State of Colorado, the University of Colorado, and the Coleman Institute. As for the recession, its founders say the company will be keeping close tabs on the funding and partnership environment over the next two to three years, despite already being funded for drug development work for the next three years.
Key to startup success: "Be persistent in the development of your data and business model to enable you to create a financial model that has a high likelihood of helping patients and therefore is fundable by the investor community."